The Top 20 Global Pharmaceutical Companies by Sales

The table below lists the top 20 global drug companies based on sales in 2009:

S.No. Company Ticker 2009 Revenues in US $ (Milllions)
1 Pfizer PFE $45,448
2 Sanofi-Aventis SNY $40,871
3 Novartis NVO $38,455
4 GlaxoSmithKline GSK $36,746
5 AstraZeneca AZN $31,905
6 Merck & Co. MRK $26,929
7 Johnson & Johnson JNJ $22,520
8 Eli Lilly & Co. LLY $20,629
9 Bristol-Myers Squibb BMY $18,808
10 Abbott Laboratories ABT $16,486
11 Takeda Chem Ind. TKPYY $14,204
12 Boehringer-Ingelheim   $14,027
13 Teva Pharma TEVA $13,814
14 Bayer Schering BAYRY $13,344
15 Astellas   $10,509
16 Daiichi-Sankyo   $9,757
17 Eisai ESALY $8,441
18 Otsuka   $7,717
19 Gilead Sciences GILD $6,469
20 Mylan MYL $5,015

Source: Contract Pharma

Otsuka, Gilead and Mylan are new to this list. Half of the companies ranked 11-20 are based in Japan. Though currently ranked at number 13, Israel-based Teva (TEVA), the world’s largest generic drug maker, has revenue goals that could propel it into the top 7 ranks in the next few years. US-based Gilead (GILD) primarily focuses on developing drugs for life-threatening diseases diseases such as HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.

Related:

The Top 10 Global Biopharmaceutical Companies by Sales

Did you enjoy this post? Why not leave a comment below and continue the conversation, or subscribe to my feed and get articles like this delivered automatically to your feed reader.

Comments

[...] few days ago we reviewed the top 20 global pharmaceutical companies by sales. In this post, lets take a quick look at the top 10 global biopharmaceutical firms based [...]

[...] few days ago we reviewed the top 20 global pharmaceutical companies by sales. In this post, lets take a quick look at the top 10 global biopharmaceutical firms based [...]

Hello David,

this ranking is bizarre

Roche is a Global pharma, isn’t it ? I do not agree with the guys from Contract Pharma when they get Roche in a different ranking (“Biopharma”)

Sales 09 (Roche): 49,051 Swiss francs($43,623)

Regards,sacha

Sacha
Yes.I was not sure either why they did that.Only thing that was mentioned was the Genentech takeover.I have always thought of Roche as a global pharma company.

Let me send them an email and see what they respond regarding this issue. Thanks for your comment.

-David

Leave a comment

(required)

(required)